In the aspect of tumor immune biology, PD-1 inhibits signaling downstream of the T cell receptor to regulate immune cell activity within tissue and tumors, when engaged by its two ligands, PD-L1 and PD-L25. The gene discussed is CD274; the disease is neoplasm.